2023 annual financial data
Zhengye Biotechnology Holding 2023 Operating margin
Direct answer
Operating margin was 21.25%.
Operating income was 44,986,000 CNY and net income was 31,457,000 CNY.
Operating cash flow was 48,184,000 CNY.
Get free Zhengye Biotechnology Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 211,651,000 CNY
- Operating income
- 44,986,000 CNY
- Net income
- 31,457,000 CNY
- Operating cash flow
- 48,184,000 CNY
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Zhengye Biotechnology Holding financial years